Vasant Narasimhan, Novartis CEO, joins 'Money Movers' to discuss the company's quarterly earnings results. Hamas Reacts to New Pope Leo XIV Pappas Restaurants rescues bankrupt Mexican restaurant ...

FRANKFURT, Jan 31 (Reuters) - The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization and related programmes risks harming ...

Carlos succeeds Dan Sceli, CEO of Westport, who held the position on an interim basis since the closing of the joint venture transaction in June 2024 and will continue to sit on Cespira’s board.

Stellantis CEO Carlos Tavares abruptly resigned from his position at the automaker, citing a difference in views. The board accepted his resignation, effective immediately, and created a Special ...

Stellantis CEO Carlos Tavares has resigned effective immediately. An executive committee will run the company before selecting a new CEO in the first half of 2025. The move is a departure from ...

Carlos Tavares, chief executive officer of Stellantis. Photo: Getty Images Stellantis Chief Executive Carlos Tavares resigned abruptly on Sunday, two months after a profit warning at the maker of ...

Novartis raised its mid-term CAGR sales growth ... with eight marketed brands expected to generate $3 billion to $8 billion at peak sales. CEO Vas Narasimhan noted increased peak sales estimates ...

Novartis has slimmed down its clinical-stage programs by nearly 40% in recent years as the Big Pharma “took to heart” data showing it wasn’t getting good value from its medicines ...

Narasimhan is confident that Novartis will achieve its goal of increasing sales by an average of 5% annually by 2028. This will be made possible by eight to nine medicines, which Novartis expects ...

ZURICH, Nov 2 (Reuters) - Novartis (NOVN.S), opens new tab expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday ...

Novartis CEO Vas Narasimhan talks to CNBC about the company's latest results and the potential impact of the U.S. election on the business. New Canadian PM Mark Carney vows to fight US trade war ...

Novartis (NVS) recently announced a partnership with Alphabet (GOOG,GOOGL) owned Isomorphic Labs, which will leverage its AI platform to develop small molecule drugs.